10.89
Overview
News
Price History
Option Chain
Financials
Why WBA Down?
Discussions
Forecast
Stock Split
Dividend History
Walgreens Boots Alliance Inc stock is traded at $10.89, with a volume of 7.85M.
It is up +0.83% in the last 24 hours and down -3.29% over the past month.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
See More
Previous Close:
$10.80
Open:
$10.8
24h Volume:
7.85M
Relative Volume:
0.36
Market Cap:
$9.43B
Revenue:
$147.66B
Net Income/Loss:
$-8.64B
P/E Ratio:
-1.0879
EPS:
-10.01
Net Cash Flow:
$-363.00M
1W Performance:
+1.87%
1M Performance:
-3.29%
6M Performance:
+2.16%
1Y Performance:
-38.23%
Walgreens Boots Alliance Inc Stock (WBA) Company Profile
Name
Walgreens Boots Alliance Inc
Sector
Industry
Phone
(847) 315-2500
Address
108 WILMOT ROAD, DEERFIELD, IL
Compare WBA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
WBA
Walgreens Boots Alliance Inc
|
10.89 | 9.43B | 147.66B | -8.64B | -363.00M | -10.01 |
![]()
WGRX
Wellgistics Health Inc
|
3.29 | 198.95M | 0 | 0 | 0 | 0.00 |
![]()
HITI
High Tide Inc
|
2.31 | 165.11M | 376.07M | -22.41M | 18.73M | -0.298 |
![]()
PETS
Petmed Express Inc
|
3.09 | 62.38M | 270.52M | -6.08M | 17.42M | -0.2944 |
![]()
HKPD
Hong Kong Pharma Digital Technology Holdings Ltd
|
0.9067 | 13.97M | 0 | 0 | 0 | 0.00 |
Walgreens Boots Alliance Inc Stock (WBA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-28-25 | Downgrade | Deutsche Bank | Hold → Sell |
Feb-26-24 | Initiated | Leerink Partners | Market Perform |
Feb-20-24 | Downgrade | HSBC Securities | Hold → Reduce |
Jan-03-24 | Initiated | Barclays | Underweight |
Dec-22-23 | Initiated | HSBC Securities | Hold |
Oct-23-23 | Upgrade | JP Morgan | Neutral → Overweight |
Jul-03-23 | Reiterated | Morgan Stanley | Underweight |
Jun-28-23 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-23-23 | Initiated | Loop Capital | Buy |
Nov-23-22 | Resumed | Morgan Stanley | Underweight |
Nov-22-22 | Upgrade | Cowen | Market Perform → Outperform |
Nov-18-22 | Upgrade | JP Morgan | Neutral → Overweight |
Nov-11-22 | Upgrade | Deutsche Bank | Hold → Buy |
Apr-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
Dec-16-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
Mar-25-21 | Reiterated | Deutsche Bank | Hold |
Jan-11-21 | Upgrade | Guggenheim | Neutral → Buy |
Jan-11-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
Jan-08-21 | Resumed | Credit Suisse | Neutral |
Apr-06-20 | Upgrade | UBS | Sell → Neutral |
Apr-03-20 | Upgrade | Deutsche Bank | Sell → Hold |
Dec-11-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
Oct-30-19 | Reiterated | Pivotal Research Group | Hold |
Oct-23-19 | Downgrade | JP Morgan | Overweight → Neutral |
Sep-27-19 | Resumed | RBC Capital Mkts | Sector Perform |
Sep-12-19 | Initiated | Deutsche Bank | Sell |
Apr-18-19 | Initiated | Guggenheim | Neutral |
Apr-03-19 | Downgrade | Loop Capital | Buy → Hold |
Apr-03-19 | Reiterated | Pivotal Research Group | Hold |
Mar-08-19 | Reiterated | BofA/Merrill | Underperform |
Jan-17-19 | Initiated | UBS | Sell |
Dec-19-18 | Resumed | Wolfe Research | Peer Perform |
Dec-14-18 | Downgrade | Goldman | Neutral → Sell |
Oct-15-18 | Reiterated | Pivotal Research Group | Hold |
Oct-08-18 | Reiterated | RBC Capital Mkts | Outperform |
Jul-10-18 | Downgrade | Evercore ISI | Outperform → In-line |
Jul-09-18 | Downgrade | Citigroup | Buy → Neutral |
Jul-02-18 | Reiterated | Pivotal Research Group | Hold |
Jun-29-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Walgreens Boots Alliance Inc Stock (WBA) Latest News
Walgreens To Pay DOJ $300M Over Invalid Prescriptions - Law360
Walgreens Boots Alliance (WBA) Reaches Settlement with DOJ Over Opioid Dispensing Rules - GuruFocus
Walgreens settles opioid litigation for $300 million - Investing.com
Hanes' CLO Resigns For 'Another Business Opportunity' - Law360
Walgreens Boots Alliance (WBA): Strong Industry, Solid Earnings Estimate Revisions - TradingView
6 ways your pharmacist can support your health and wellness - Walgreens Boots Alliance
Wells Fargo & Company MN Has $10.09 Million Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Franklin Resources Inc. Decreases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) - Defense World
Arrowhead Pharma Taps Walgreens Finance Chief to Lead Commercial Stage Transition - Stock Titan
Walgreens: Acquisition Is The Best-Case Scenario For The Company - Seeking Alpha
Sycamore Partners’ plan to takeover Walgreens ‘incredibly risky,’ analyst says - Healthcare Brew
More Walgreens Locations Set to Shut Down in Connecticut This May - NewsBreak: Local News & Alerts
No shortage of egg-inspired options this Easter at Walgreens - Walgreens Boots Alliance
Form PREM14A Walgreens Boots Alliance For: Apr 14 - StreetInsider
Private Equity Firm Acquires Parent Company of Walgreens and Duane Reade - Dark Daily
Walgreens Comeback? Private Equity Circling for a Buyout - MarketBeat
Down 89%, Should You Buy the Dip on Walgreens Boots Alliance? - AOL.com
Walgreens Boots Alliance (WBA) Exceeds Earnings and Revenue Expe - GuruFocus
Robbie Huffines - Walgreens Boots Alliance
'Discipline And Dedication To Excellence' Propelled Rosalind 'Roz' Brewer To Become One Of Few Black Women CEOs In Fortune 500 - AfroTech
What Does the Market Think About Walgreens Boots Alliance? - Benzinga
Inside Walgreens PetShoppe: For pets and their people - Walgreens Boots Alliance
Walgreens Boots Alliance (NASDAQ:WBA) Now Covered by Analysts at StockNews.com - Defense World
Walgreens Boots Alliance: Last Chance To Buy (NASDAQ:WBA) - Seeking Alpha
Boots sales nudge up amid Walgreens turnaround plan - Retail Gazette
Walgreens Boots Alliance Q2 2025: sales up 4.1 percent but EPS plummets - Global Cosmetics News
Walgreens Beats on Q2 Earnings, Withdraws Fiscal 2025 View, Stock Down - Zacks Investment Research
Walgreens Boots Alliance sees net loss narrowed in Q2 FY25 - Yahoo Finance
Wisconsin Hit Hard in Walgreens’ Store Closures—See If Your Location Is Affected - NewsBreak: Local News & Alerts
Decoding Walgreens Boots Alliance Inc (WBA): A Strategic SWOT Insight - GuruFocus
Walgreens Boots Alliance Reports Q2 Fiscal 2025 Results - TipRanks
Tariffs Won't Stop Walgreens Buyout, Barclays Says - WSJ
1 Dividend Stock Yielding More Than 6% to Buy Now - The Globe and Mail
Walgreens Tops Earnings Forecast, Withdraws Guidance Amid Privatization Efforts - TradingView
WBA stock price: Walgreens beats on revenue in one of its last earnings reports as a public company - Fast Company
Walgreens’ retail sales down in Q2 as pharmacy giant prepares to go private - Supermarket News
Walgreens Boots Alliance Sees Sales Growth And Earnings Beat - Finimize
Walgreens' Public-Company Journey at an End With a $24 Billion Buyout - Morningstar
Walgreens (WBA) Faces Market Challenges Amid Tariff Concerns - GuruFocus
Walgreens tops fiscal 2Q forecasts as private equity buyout awaits - 5 EYEWITNESS NEWS
Walgreens Surpasses Fiscal 2Q Forecasts Amidst Strategic AcquisitionNews and Statistics - IndexBox
Walgreens Boots Alliance Tops Quarterly Results, Withdraws Guidance - MarketScreener
Walgreens Tops Fiscal 2Q Forecasts as Private Equity Buyout Awaits - U.S. News & World Report
Walgreens Boots Alliance (WBA) Posts Robust Earnings Amid Sector Challenges - GuruFocus
Walgreens Boots Alliance Reports Fiscal 2025 Second Quarter Results - Walgreens Boots Alliance
Walgreens Boots Alliance, Inc. (WBA): Jim Cramer Says “Zombie Firm” No More – Can Private Equity Save Walgreens? - Insider Monkey
Walgreens beats profit estimates ahead of Sycamore Partners deal - Reuters
Walgreens, CVS, & US drugmakers make big moves: What to know - Yahoo Finance
Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Deal - Yahoo Finance
Walgreens narrows loss in Q2; turnaround still in ‘early stages’ - Chain Store Age
Walgreens Tops Profit Estimates as Health-Care Unit Improves - Bloomberg.com
Walgreens Boots Alliance Inc Stock (WBA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Walgreens Boots Alliance Inc Stock (WBA) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Walgreens Boots Alliance, Inc. | 10% Owner |
Feb 06 '25 |
Sale |
244.51 |
1,286,376 |
314,531,796 |
12,570,000 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):